The metabolic syndrome is defined as a clustering of key cardiovascular risk factors, namely, abdominal obesity, dyslipidemia, hyperglycemia and hypertension in a single individual. Gerald Reaven introduced the concept of the syndrome in 1988.This crosssectional study was conducted in 120 in which 60 non diabetic and 60 type 2 diabetic patients, 2013 to 2015 in the department of biochemistry, Mediciti Institute of Medical Sciences, Hyderbad. Ethical clearance was obtained for the study. Informed consent was obtained. 60 subjects with type 2DM were included in the study. Subjects in the age group of 30-65 yrs in both genders, meeting the Type 2DM, FBS and PLBS meeting the criteria were taken up in the study. Maximum prevalence of Metabolic syndrome was observed in diabetic male harmonised criteria (73.3%) and diabetic female WHO criteria (76.6 ). A fair agreement was observed between WHO and HAR criteria by Kappa statistics. A two tailed significant correlation were found in diabetic male patients (using WHO,HAR criteria ) than female patients (using CDS) criteria.